-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T1tFvRK8KBR65ibWzz9SjD7ehT28pO3E2mNljQFAmxu3uJ6g5FFB1FywHr/CFPDD /S5gv+tq4TO0zu+QawkMjQ== 0001181152-10-000001.txt : 20100105 0001181152-10-000001.hdr.sgml : 20100105 20100105131551 ACCESSION NUMBER: 0001181152-10-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100104 FILED AS OF DATE: 20100105 DATE AS OF CHANGE: 20100105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONDURANT STUART CENTRAL INDEX KEY: 0001181152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 10505508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-01-04 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181152 BONDURANT STUART 205 UNIVERSITY DRIVE CHAPEL HILL NC 27514 1 0 0 0 Common Stock 2010-01-04 4 A 0 2799 0 A 17844 D Stock Options (to buy) 19.86 2009-05-20 2019-05-20 Common Stock 13577 13577 D Stock Options (to buy) 42.77 2008-05-21 2018-05-20 Common Stock 6265 6265 D Stock Options (to buy) 33.82 2007-05-16 2017-05-16 Common Stock 6126 6126 D Stock Options (to buy) 35.38 2006-05-17 2016-05-16 Common Stock 3973 3973 D Stock Options (to buy) 23.79 2005-05-18 2015-05-17 Common Stock 5458 5458 D Lisa C. Noecker attorney-in-fact for Stuart Bondurant 2010-01-05 -----END PRIVACY-ENHANCED MESSAGE-----